In 2025, a team of scientists revealed some unexpected findings about how the inherited DNA repeat associated with Huntington ...
Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate RNA ...
Reducing the expression of MSH3 in neurons could slow expansion of CAG repeats in the huntingtin gene ...
An experimental gene therapy has become the first treatment to successfully slow the progression of Huntington’s disease. While the findings are still preliminary, the approach could be a major ...
Huntington's disease (HD) has long been impossible to cure, but new research is finally giving fresh hope. HD is a progressive, hereditary brain disease that affects movement, cognition and emotions.
People who carry the genetic mutation for Huntington's disease report more trouble controlling their emotions when they also ...
In a small trial, a gene therapy injected into the brain slowed the disease by 75 percent over three years. Huntington’s disease is extremely cruel. Symptoms start with random, uncontrollable twitches ...
About 8,000 people in the UK are living with Huntington’s disease, a devastating inherited condition that gradually affects movement, thinking and mood. Now, an advanced type of MRI scan could give ...
Read the latest research news on Huntington's Disease. Learn about genetic risks, potential new treatments and more.
A preliminary study of 52,330 Israeli women found similar rates of heart attack, stroke, blood clots and early death among hormone therapy users and nonusers, though it cannot prove safety. Older ...
12don MSN
2023 Helpcurehd Gala: LaForce and Smith raise record $600,000; IVF grants aid Huntington’s families
In September 2023, Allie LaForce and Joe Smith hosted their annual HelpCureHD gala in Houston. The event raised $600,000 for ...
The Oshkosh Northwestern on MSN
Huntington’s disease fundraiser returns to Neenah Aug. 9
The Fox Valley Team Hope Walk will raise money Aug. 9 in Neenah for Huntington’s disease support programs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results